Clinical trial
The STOP-MED CTRCD Trial
NCT06183437
Study timeline
Study start (actual)2024-03-04Date precision: day
Registry last updated2026-07-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Failureverified · MONDO: heart failure
Cardiotoxicityunresolved
Cardiac Toxicityunresolved
Antineoplastics Toxicityunresolved
Cancerverified · MONDO: cancer
Interventions
Sponsors & collaborators
Dinesh Thavendiranathanlead sponsor
Unity Health Torontocollaborator
Hamilton Health Sciences Corporationcollaborator
St. Boniface Hospitalcollaborator
Ottawa Heart Institute Research Corporationcollaborator
University College London Hospitalscollaborator
Brigham and Women's Hospitalcollaborator
Baker Heart and Diabetes Institutecollaborator
University of California, Los Angelescollaborator
Alberta Health servicescollaborator
Hospital Universitario La Pazcollaborator
Guy's and St Thomas' NHS Foundation Trustcollaborator
Memorial Sloan Kettering Cancer Centercollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06183437 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.